In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...
News-Medical.Net on MSN
Chemotherapy-based conditioning matches outcomes of total body irradiation for MRD-negative B-ALL
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
While traditional methods like blood tests and microscopic examination remain important, modern technology offers far greater ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...
Members of Fulcrum management will be joined by Dr. Sheinei Alan, Director of the Inova Adult Sickle Cell Program and Assistant Professor at UVA School of Medicine, and Dr. Martin Steinberg, Professor ...
Demographics: The New Center of Gravity Wealth management is undergoing a structural demographic shift as assets move from ...
Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...
The Honourable Stephanie McLean, Secretary of State (Seniors), on behalf of the Honourable Marjorie Michel, Minister of Health, will make an announcement about the Canadian Dental Care Plan and ...
Two oral, and five poster presentations will showcase the company’s progress in developing allogenic cell therapy candidates for multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback